Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8745 EUR | -0.85% | -2.73% | -15.23% |
May. 08 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.23% | 640M | |
+30.38% | 684B | |
+29.52% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+15.87% | 240B | |
+9.28% | 208B | |
-7.28% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Reports Data on Leniolisib Trial to Treat Rare Immunodeficiency